| project details | |
|---|---|
|
Acronym |
RadioVal
|
|
Title |
International Clinical Validation of Radiomics Artificial Intelligence for Breast Cancer Treatment Planning
|
|
Duration |
Nov 2024 – Aug 2026 |
|
GA Number |
101057699
|
|
Programme |
Horizon Europe |
|
Action type |
RIA |
|
Call |
HORIZON-HLTH-2021-DISEASE-04-04
|
|
Field |
|
|
Coordinator |
Universitat de Barcelona |
|
Description
|
RadioVal is the first multi-centre, multi-continental and multi-faceted clinical validation of radiomics-driven estimation of NAC response in breast cancer. The project builds on the repositories, tools and results of five EU-funded projects from the AI for Health Imaging (AI4HI) Network, including a large multi-centre cancer imaging dataset on NAC treatment in breast cancer. SHINE is leading Work Package 1 – Multi-stakeholder engagement and social innovation, developing the methodology to involve citizens, professionals, patients, public authorities and other relevant actors in the evaluation and implementation of radiomics and Artificial Intelligence tools in breast cancer treatment. SHINE will also be leading the impact assessment process concerning the socio-ethical implications of this work, including the diversity of contexts, countries and populations. |
|
Website |
|
|
Social Media |
|
|
Partners |
|